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DAPATAN KLINIKAL DAN BEBANAN EKONOMI PESAKIT YANG 
MENGALAMI DIABETES MELLITUS DAN TUBERKULOSIS DI TIGA 
BUAH HOSPITAL DI MALAYSIA                                                                                                         
ABSTRAK 
 
Prevalens diabetes mellitus (DM) di Malaysia telah berkembang ke tahap epidemik.  
Sejak sekian lamanya peningkatan suseptibiliti pesakit diabetes terhadap penyakit 
berjangkit termasuk tuberkulosis (TB) telah dilaporkan. Jenis kajian adalah kohort 
berasaskan prevalens.  Pesakit dalam kajian ini dibahagikan kepada tiga (3) 
kumpulan: Pesakit TB sahaja; Pesakit dengan DM sahaja; Pesakit yang mengalami 
DM dan TB.  Setiap kumpulan terdiri daripada 200 orang subjek.  Pesakit diabetes 
distratakan ke dalam tiga kategori umur. Pada awalnya, pesakit dikenal pasti secara 
rentas silang (cross-sectional) selama dua tahun. Dalam tempoh kajian, iaitu  Mac 
2005 – Mac 2008, setiap fail perubatan pesakit diteliti sekurang-kurangnya dua kali: 
pada awal kajian dan selepas dua tahun 
Borang pengumpulan data yang memberikan  maklumat tentang demografi dan 
klinikal pesakit digunakan. Pesakit TB dikelaskan berdasarkan penyakit: pulmonari, 
ekstrapulmonari, dan gabungan pulmonari dan ekstrapulmonari TB. Prevalens DM 
dan HIV dalam kalangan pesakit TB dinilai. Dapatan rawatan TB, komplikasi 
berkaitan dengan TB, dan jangkamasa jangkitan TB di nilai.  Keutamaan diabetes 
dan TB dalam kalangan pesakit DM-TB ditentukan. Pesakit diabetes di bahagikan 
dalam tiga kategori umur. Jangkamasa hipertensi dan diabetes dikaji untuk 
menentukan yang mana didapati lebih utama. Untuk semua kumpulan, jumlah 
penyakit kronik dan komorbiditi yang terhasil sewaktu kajian ini dinilaikan. Selepas 
pengenalpastian  sumber  dan rawatan perubatan yang digunakan oleh pesakit,  maka 
 xviii 
kos bagi rawatan tersebut dinilai.  Prevalens DM dan HIV dalam kalangan pesakit 
TB adalah 7.7 dan 29.9%  masing-masing. Secara demografik, dalam kalangan 
kumpulan DM-TB terdapat lebih ramai lelaki(72%) dan merokok (45.5%) 
berbanding dengan 58.3% dan 33.5% masing masing dalam kalangan kumpulan TB. 
Prevalens TB pulmonary didapati lebih ramai dalam kalangan Cina(83.7%) dan India 
(75.5%) berbanding dengan 66.7% dalam kalangan pesakit Melayu. Wanita melayu 
lebih prevalens dalam kalangan pesakit DM sahaja.Perokok adalah lebih prevalens 
dalam kalangan pesakit Cina sementara pesakit India lebih kerap mengambil alkohol. 
Pesakit melayu juga didapati lebih prevalens dalam kalangan kumpulan TB sahaja. 
Secara klinikal 74% dari kalangan pesakit DM-TB mempunyai sputum yang positif 
berbanding dengan 51% dalam kalangan TB sahaja. Lebih kurang 87% dalam 
kalangan DM-TB yang mempunyai TB pulmonary berbanding dengan 59.% dalam 
kalangan TB sahaja. Kumpulan DM-TB juga mempunyai kadar mortality yang tinggi 
(15 kes) berbanding dengan 2 kes dalam kalangan TB sahaja. Kumpalan TB 
mempunyai pesakit yang lebih muda (purata 44.4 tahun) dan yang kurang berat 
badan (purata 49.3 kg) berbanding dengan purata 55.1 tahun dan 56.1kg masing 
masing dalam kalangan TB sahaja.  Kumpulan TB sahaja juga terdapat pembedahan 
yang lebih tinggi (43%) berbanding dengan 17% dalam kumpulan DM-TB. 
Jangkamasa simptom TB didapati lebih panjang dalam kalangan kumpulan TB 
sahaja (4.5 bulan) berbanding dengan 2.6 bulan dalam kalangan TB sahaja. Dengan 
pengecualian pada COPD, semua penyakit kronik yang wujud bersama-sama adalah 
lebih prevalens dalam kalangan wanita. Kumpulan Diabetes mempunyai lebih 
banyak komorbiditi dan jangkamasa diabetes dan hipertensi yang lebih lama. 
Diabetes terjadi lebih awal berbanding hipertensi dan tuberculosis iaitu selama 4 
tahun. Secara ekonomik, kos total kumpulan DM-TB adalah RM 4530 berbanding 
 xix 
RM 3082.8 dalam kalangan TB sahaja dan RM 6945.26 dalam kumpulan DM sahaja.  
Kos untuk penggunaan ubat ubatan secara kronik adalah RM 1663.5 untuk kumpulan 
DM-TB berbanding RM 631.7 untuk kumpulan TB sahaja dan RM 5160 untuk DM 
sahaja.  
Kata kunci: Tuberkulosis, Bebanan Penyakit, Diabetes Mellitus, Kos, Mortaliti, 
Malaysia. 
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CLINICAL OUTCOMES AND ECONOMIC BURDEN OF PATIENTS HAVING DIABETES 
MELLITUS AND TUBERCULOSIS IN THREE HOSPITALS IN MALAYSIA  
 
 
ABSTRACT 
The prevalence of diabetes mellitus (DM) in Malaysia is growing to the epidemic 
level. Since a long time increased susceptibility of diabetic patient to wide range 
infectious diseases including tuberculosis (TB) has been reported. This study was 
intended to assess the clinical outcomes and economic burden of combined DM-TB 
condition. The type of this study is prevalence based prospective cohort. Study 
patients were divided into three groups: patients with TB infection only; patients 
with DM only; patients with coexistence of DM and TB. Each group included 200 
subjects. Cases (DM-TB) were compared separately with DM only and TB only 
groups. Patients were first identified as cross-sectional and followed for a minimum 
of two years. During study period, March 2005-May 2008, each patient's medical file 
was reviewed at the beginning of the study and at the end of the study. Data 
collection forms containing required demographic, cost, and clinical information 
were used. TB patients were classified into pulmonary, extrapulmonary, and patients 
having both pulmonary and extrapulmonary TB. Prevalence of DM and HIV and 
other TB risk factors were studied. TB treatment outcome, TB related complications, 
and TB infectivity period were studied. Durations of hypertension, DM and TB were 
assessed. Diabetic patients were stratified into three age categories. Prevalence of 
chronic diseases was studied. A cost of health care resource utilization was studied. 
The prevalence of HIV and DM among TB patients was 7.7 and 29.9% respectively. 
Demographically, DM-TB group had more male gender (72%) and smokers (45.5%) 
compared to 58.3% and 33.5% respectively in TB group. Prevalence of pulmonary 
TB was more in Chinese (83.7%) and Indians (75.5%) compared to 66.7% in 
 xxi 
Malays. Smokers were more prevalent in Chinese race, while Indians were more 
prevalent in alcoholics. Clinically, 74% of DM-TB patients were sputum positive 
compare to 51% in TB only. About 87% of DM-TB subjects had pulmonary TB 
compared to 59.5% in TB only group. DM-TB subjects also had more mortality rate 
(15 cases) compared to 2 cases in TB only group. TB only group had younger (44.4 
years) and underweight subjects (49.3Kg) compared to 55.1 years and 56.1 Kg 
respectively in DM-TB group. Also TB only group showed more surgical operations 
(43%) compared to 17% in DM-TB group. TB symptom period was longer in TB 
only group (average of 4.5 months) compared to average of 2.6 months in DM-TB 
subjects. With the exception of COPD, all coexisting chronic diseases were more 
prevalent in females. Females were also more prevalent in DM only group. DM 
group had more comorbid, and longer history of diabetes mellitus and hypertension. 
Diabetes antedated hypertension and tuberculosis nearly for 4 years. The total cost of 
DM-TB group during the two years of study period was RM4530 compared to RM 
3082.8 in TB only and RM 6945.26 in DM only group. Cost of chronic medicines 
during the two years of study was RM1663.5 for DM-TB group compared to RM 
631.7 for TB only group and RM 5160 for DM only subjects. In conclusion, 
compared to TB only, DM-TB group showed more severe condition, higher 
mortality, and higher cost of treatment. DM only group showed higher number of 
comorbidity and cost of treatment.  
 
 Keywords: Tuberculosis, Diseases Burden, Diabetes Mellitus, Cost, Outcomes, 
Mortality, Malaysia.  
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Background  
Tuberculosis (TB) is bacterial infectious disease caused by Mycobacterium 
tuberculosis. The disease is the leading cause of death among infectious diseases, 
and around 2 million people died from TB in 2008 (WHO, 2011). Although fast 
increasing incidence of HIV diverted the world's concentration on the other 
infectious diseases, TB remained, especially in developing countries, as an important 
threat to the human health. As stated by Iseman (2000), tuberculosis has probably 
killed 100 million people over the past 100 years, although a cure was available in 
second half of the 20th century (Thomas et al., 2003).  
 
A strong correlation between illiteracy and poverty on one side, and 
tuberculosis on the other side is well documented. TB mainly affects disadvantaged-
lower class people. Even within rich countries, TB mainly affects categories with 
lower level of education and income (Baker et al, 2008). The load of TB is 
overwhelmed with the increasing rate of HIV coexistence, multiple drug resistant 
TB, and homelessness. In 1993, the World Health Organization took an 
unprecedented step of declaring tuberculosis a global emergency (Ho, 2004).  
  
Although an appropriate combination of antibiotics could cure 95 percent of 
tuberculosis and the widespread application of the only currently available vaccine, 
Bacille Calmette Guerin (BCG), tuberculosis is still out of control in certain areas of 
the world (WHO 2011). The disease that appeared to have been conquered in 
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developed countries in the twentieth century by biomedicine armed with powerful 
antibiotics began to reverse in the late 1980s. 
 
There are numerous social and medical risk factors for tuberculosis. These 
risk factors are varied among different regions and social categories. Among well- 
documented TB risk factors are poverty, illiteracy, HIV, DM, and silicosis (Boucot 
1957, Concato and Rom, 1994, Gandy & Zumla, 2002). 
Diabetes mellitus (DM) is well documented as a medical risk factor for TB. 
Although the reason is not yet well elucidated, diabetic patients are more susceptible 
to infectious disease including tuberculosis than are non diabetic subjects (Boucot 
1957, Masoodi et al, 2006).   
 
Recently, as a result of economics and health services reforms in many 
countries and increased demand of health related technology, health economics 
studies are revolutionized.  Economics of all chronic diseases and specifically 
diabetes became a matter of great interest because of increased life expectance, 
changes in priorities of the health care services that took place in many countries, and 
the advance that was made about the knowledge in prevalence, complications, and 
the intensive diabetic therapy. The more market-oriented approach to health services 
has sharply affected the rational distribution of the health care services (Gandy & 
Zumla, 2002). In Vietnam, during economic reforms, low income categories who 
could not pay according to the market cost suffered from inequality of health services 
(Dao et al., 2008).  
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1.2 Research Problem: Clinical Outcomes and Economic Burden of Patients 
Having Diabetes Mellitus and Tuberculosis in Three Hospitals in Malaysia  
Resurgence of TB in the late 80s was attributed to numerous risk factors such 
as HIV, low TB project funding, migration from TB epidemic area, drug-abuse, and 
others. However, the role of diabetes mellitus was not highlighted. The burden of 
disease (BOD) in study includes epidemiology, morbidity, mortality and costs 
associated with the disease. The incidence and/or prevalence of disease are first 
studied and the percentage of people affected is reported. After stating the portion of 
a society affected by any disease, it is common to evaluate how far is the severity of 
the disease on affected people (morbidity), and if there are any complications that 
may result from the disease as well as the mortality attributable to the disease. 
Finally, the cost of the disease at different levels including the person affected, health 
care providers, and whole society is evaluated. Although BOD is sometimes 
expressed in the terms of cost of illness, however, more components are 
encompassed by BOD. BOD is measured by prevalence of the disease, morbidity, 
mortality, cost of illness as well as the disability adjusted life years (DALY) (Nahin, 
2005). The burden of illness is first identified through epidemiological study, and 
then, the burden is translated into monetary unit.  
 
1.3 Rationale for the Study  
Although Malaysia is an Asian country with intermediate burden of TB, and 
is close to high TB burden countries; however, studies related to TB risk factors in 
the region are lacking. After searching through English medical literature, no studies 
related to the burden of DM-TB were done in Malaysia or other neighbouring 
countries, or even globally. Studies assessing complications of DM-TB are limited, 
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and require more details. High percentage of TB patients is diabetic, and implication 
of DM on TB is not well elucidated. The majority of the studies were cross-sectional 
diagnosis based estimates from population, or projection from previous studies and 
involve only a part of direct medical costs. Individualized studies like this research 
with reasonable follow-up time and assessing outcomes and complications related to 
the TB are time consuming and expensive, but reliable. 
 
1.4 Hypothesis 
The clinicians and researcher in Malaysia feel the significance of coexistence 
of DM and TB, and as a result there are two hypotheses in this study: 
 Is the DM a leading risk factor for TB in Malaysia compared to other 
factors like HIV, multiple drug resistant TB, and drug-abuse?. 
  Is the coexistence of DM and TB has impact on complications and 
treatment expenditure compared to DM only or TB only conditions?. 
Null hypothesis: DM is not a leading TB risk factor in Malaysia, and comorbidity of 
DM and TB has no impact on the complications and cost of treatment of TB patient. 
 
1.5 Significance of the Study 
  The study is highlighting the importance of diabetes as a TB risk factor. 
Although it is known that DM patients are more susceptible to TB infection than is 
the general population, however, this awareness is poor, and if DM is mentioned in 
the medical literature as a risk factor for tuberculosis, it is mentioned at the end of a 
long list of risk factors with low priority. This is while, according to the hypothesis 
of this study, DM is the first Malaysian medical risk factor for tuberculosis. 
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On completion of this study, it is hoped that it would be able to improve the 
information related to the preventive measures for both diabetic patient and society 
against tuberculosis through: 
 a better understanding about the nature of DM-TB patient with respect to TB 
dispersion, and highlighting complications and economic burden of DM-TB, 
 the study may suggest addition of preventive measures for DM  patients, and 
  highlighting the magnitude of diabetes as a risk factor for tuberculosis which 
may encourage clinicians and researchers to conduct further studies aimed to 
reduce the progression of TB among DM patients. 
 
1.6 Aims  
Generally the aim of this study is to assess the impact of combined DM-TB 
condition on the affected person, society as well as the resources of the country. 
 
1.6.1 Objectives 
Specifically, the objectives of this research are   
 To determine the prevalence of diabetes and other TB risk factors 
among TB patients in Malaysia. 
 To assess the association between DM and TB in the terms of 
complications and cost of illness. 
 To assess differences of TB care in different hospitals and relation of 
this differences to the TB outcome. 
 To highlight the severity of the combined DM-TB condition on the 
affected patients and the general population.  
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1.7 Theoretical and Conceptual Frame Works 
Theoretically, DM patients suffer from immune dysfunction which negatively 
affects natural body’s defence mechanism against infectious diseases like TB. The 
immune dysfunction and other factors like smoking and poverty may accelerate 
opportunistic infection with the resultant severe pathogenic status (see Fig 1.1).  
Conceptual frame work of the study and its steps is shown in Fig 1.2. 
 
DM 
Immune Dysfunction 
DM-TB Unhealthy 
life style 
Illiteracy 
Smoking 
Poverty 
Severe Pathogenic 
condition  
More 
sputum 
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Increased 
morbidity 
Increased 
expenditure  
 
Figure 1.1: Theoretical Frame Work  
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Tuberculosis 
2.1.1 Epidemiology of tuberculosis 
Estimation and assessment of TB burden is difficult especially in those 
countries with poor infrastructure (Begum et al., 2007). However, after AIDS, 
tuberculosis is the world's commonest cause of death from infectious diseases 
(Thomas et al., 2003). Around one third of the world's human population has been 
infected by Mycobacterium tuberculosis (WHO, 2011). In 2008, there were around 
11 million active TB cases including 9.4 million new cases. Only 5.7 million were 
detected including 2.7 million sputum-smear positive cases (WHO, 2011). TB causes 
the death of millions of people each year including 100,000 children under the age of 
5 (Gandy & Zumla, 2002). Although mortality from TB disease has substantially 
declined in the developed countries, the situation in the developing countries has 
been totally different. TB disease remained, especially in poor countries one of the 
most feared and stigmatized disease (Saunderson, 1995). There is growing 
recognition that the conquest of this disease cannot be achieved by medical advances 
alone. The disease is a complex interplay between political, social, economic, 
cultural, and biological factors. The emergency of drug resistant strains of TB, the 
prevalence of coinfection with HIV and social and economic factors are the main 
contributory factors of the disease.  
      
Geographically, prevalence of TB varies. In Malaysia, TB notified cases per 
100,000 people were 80, 64.7, and 48 in 1977, 2000, and 2006 respectively (Iyawoo, 
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2004, NHMS III, 2006). In US, since the middle of the19
th
 century, the disease has 
been following a decreasing trend of mortality rates from 194.4 per 100,000 in 1900 
to 9.0 per 100,000 in 1955 (Boucot, 1957).  Currently, incidence of TB ranges from 8 
per 100,000 populations in rich countries like North America and Western Europe to 
410 per 100,000 in low income countries (WHO, 2011). In rich countries, the disease 
is the disease of the inner city and urban population where socially lower classes 
reside. According to the New York City Department of Health, the incidence of TB 
in New York was 3 times higher than the national rate (Bashar et al. 2001). Within 
New York, the incidence was 10 times higher in the inner city compared to the other 
parts of the city. Although in earlier decades TB had been a disease of the general 
population, later on by the 1980s, TB had become primarily the disease of 
disadvantaged people.  
 
Although Sub-Saharan Africa has the highest incidence rate, China and India 
have the largest world-wide case loads. India, China, Indonesia, Bangladesh, and 
Pakistan together account for more than half the global burden. Around 80% of new 
cases occur in 22 high-burden countries. However, as per Ministry of Public Health 
(1990), the prevalence of TB was declining in China since 1979 (796 per 100,000) to 
138 per 100,000 in 2010 (China Tuberculosis Control Collaboration, 2004; WHO 
2011). Because of economic reforms, certain countries like members of the former 
Soviet Union have increased case load for the last decade. 
 
The incidence of TB is increasing in many parts of the world due to the 
unfortunate coexistence with human immunodeficiency virus (HIV) infection, poor 
living condition, and multiple drug resistance (McMurray, 2003; Ho, 2004; Needham 
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et al., 2004). People with dual infection, TB and HIV, have a higher mortality rate of 
2.5 fold. In addition to HIV infection, resurgence of TB is mainly due to drug abuse, 
and poor living conditions (Blanc-Perez et al., 1998). In America, HIV is the main 
risk factor. In a 1993 report of one of the hospitals in Atlanta, USA, about 40% of 
newly diagnosed TB was HIV positive. A similar result was reported in US 
metropolitan areas (McGowan & Blumberg, 1995). 
 
Economic factor was highlighted in earlier times when the TB disease was 
concentrated in the lower socioeconomic classes as a result of malnutrition and large 
dosage of infection due to crowding (Boucot, 1957). Poverty, infrastructural decay, 
and declining health services have facilitated the spread of TB. The more market-
oriented approach to the health care services has sharply affected the rational 
distribution of the health care services.  Even in the developed countries such as UK, 
the current increase of the disease can be attributed to widening the social inequality. 
The funding of the TB control is lower than other infectious diseases such as malaria, 
leprosy, and AIDS. Poverty and malnutrition, gender inequality, and inadequacy of 
medical services are central elements of the disease resurgence. Fear from stigma is a 
cultural factor (Gandy and Zumla, 2002). Occasionally, active tuberculosis may 
occur at higher socioeconomic levels due to the massive exposure as in case of health 
workers or as a result of comorbid with other special disease (Boucot, 1957).  
 
In the general population, tuberculosis increases with increasing age. 
However, age factor is dependent on the region. In developed countries, the disease 
mainly affects the elder population; while on the other hand, the disease mostly 
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affects people in their productive ages in developing countries (Boucot, 1957, 
Iyawoo, 2004). 
 
By sex, tuberculosis is more frequent among men than among women. Once 
infected, women in their reproductive age are more sensitive to develop TB than the 
men of the similar ages. TB is the third leading cause of death worldwide among 
women aged 15-44 (WHO, 2011). 
  
2.1.2 Diagnosis 
Diagnosis of TB depends on the likelihood that someone is susceptible to the 
infection; the state of the disease whether it is latent infection or active tuberculosis; 
anatomical site of infection, whether it is pulmonary or extrapulmonary; diagnostic 
tools, whether it is clinical, laboratory, and X-ray; screening modality, whether it is 
detected through active, passive or other ways of screening; and geographical areas. 
Diagnosis of probable TB requires at least one of three elements: positive sputum 
smear for AFB, strong clinical suggestions, and chest x-ray suggesting TB. However, 
each of these elements is relatively insensitive and non-specific (Centres for Disease 
Control and Prevention, 2011). 
  
2.1.2(a)  Physical evaluations 
Clinical manifestation of the disease partially depends on the anatomical 
organ involved and can be classified into systemic and organ related symptoms. Low 
grade of fever, weight loss, and loss of appetite are relatively non-specific systemic 
symptoms (Sepkowitz, 2001). Early tuberculosis may be asymptomatic or there may 
be vague complaints of fatigue, anorexia, low-grade fever or slight cough. On the 
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other hand, haemoptysis may be the first strong symptom. Haemoptysis may 
sometimes accompany the cough. Locally, acute pleuritic pain, high fever, sweats, 
rapid weight loss, and racking cough are manifestations of advanced pulmonary TB. 
However, the clinical manifestation of TB may be obscured by coexisting diseases 
such as HIV, DM, cancer and others. Cough which is the most common feature of 
pulmonary tuberculosis is initially non-productive, which subsequently, as a result of 
inflammation, progresses to productive (American Thoracic Society, 2000).  
 
Extra-pulmonary tuberculosis is problematic in terms of diagnosis, and costly 
because of its non-specific clinical manifestation. It is one of the challenges to 
physicians especially in those countries with low TB load. Disseminated tuberculosis 
which is also known as milliary TB results because of inadequacy of the host 
defences in containing tuberculous infection and involvement of the infection in 
multiple body organs. Because of pulmonary involvement, cough may accompany 
disseminated TB. Lymph node tuberculosis is the most frequently encountered extra-
pulmonary TB. It is characterized as a painless swelling of one or more lymph nodes. 
Supraclavicular fossa and posterior or anterior cervical chain are the most commonly 
involved sites. In children, intra-thoracic adenopathy that compresses bronchi is 
common. Fever and pleuretic pain are the manifestation of pleural TB. Effusion, 
cough and dyspnoea may also occur. Skeletal tuberculosis is characterized by 
skeletal pain, swelling of affected joints and limitation of movement. In case of 
delayed diagnosis, vertebral tuberculosis may result in compression of the spinal 
cord with severe neurological consequences (Turgut, 2001). TB meningitis can result 
from direct meningeal invasion during a tuberculosis bacillemia at the initial 
infection or at the time of occurrence of breakdown of old pulmonary and/or 
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parameningeal foci. Headache, decreased level of consciousness, and neck stiffness 
are indications of meningeal TB. Symptoms of GIT TB are not specific and require 
differential diagnosis to exclude rectal carcinoma and appendicitis (Das et al., 1996).  
     
 2.1.2(b) Laboratory investigations 
Microbiological diagnosis of TB depends on area's prevalence rate, the type 
of laboratory equipments, and personnel qualification. Specimens that are required 
for TB diagnosis include sputum, gastric aspirates, urine, cerebrospinal fluids, 
pleural fluid, bronchial washings, biopsy of suspected tissues, bone marrow, and 
others. The diagnosis of active pulmonary tuberculosis is based on adequate 
bacteriologic or tissue proof. Investigations like fine needle aspiration cytology, 
biopsy from affected lymph node or pleural ascetic are helpful for extrapulmonary 
cases (Tripalthy, 2003). At least two out of the three sputum smear should be acid-
fast bacillus positive to label the patient smear positive. Three sputum samples need 
to be taken from each person with suspected TB; one spot specimen and two early 
morning specimens. One positive sputum report is unreliable. If only one smear is 
positive, but the patient has radiological abnormalities, the case is diagnosed as an 
active pulmonary TB. In the presence of radiological abnormalities with persistent 
TB symptoms, the patient is also considered as a case of pulmonary TB, regardless 
of the result of sputum test outcomewhether it is positive or negative. When sputum 
is available, several specimens should be examined by smear and confirmed by 
culture. In the absence of sputum, cultures of gastric washing are indicated. Because 
of the possible false smear positive result due to the presence of nontuberculous acid-
fast bacilli, care should be exercised for samples taken from gastric contents. 
Detection of acid fast bacilli (AFB) through sputum stained smears under microscope 
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is considered as the first indication of Mycobacterium presence in a specimen. The 
process is very quick, easy, and inexpensive. It provides preliminary information 
about the diagnosis of TB. Because detection of AFB is not specific, differentiation 
of tuberculous and nontuberculous Mycobacterium should be performed (American 
Thoracic Society, 2000).  
 
Because of negative sputum result, bronchoscopy may be considered. If 
bronchoscopy is indicated, bronchial secretions rather than gastric washings should 
be studied. Bronchial secretions have the virtue of being aspirated directly from the 
suspected portion of the bronchial tree. 
       
Culture is more sensitive than microscopy. However, diagnosis of 
Mycobacterium tuberculosis in children is not that reliable bacteriologically as in the 
case of adult TB patient. TB confirmation bacteriologically is not more than 28% in 
children compared to 90% in adults. Identification of Mycobacterium tuberculosis 
through culture and subsequent drug susceptibility are requested for treatment of TB.  
 
On December 8, 2010, WHO endorsed a new test which is considered a 
major milestone for global TB diagnosis and care.   Nucleic acid amplification test 
(NAAT) is considered very quick and accurate test compared with currently 
available tests (WHO, 2011).    
 
The erythrocyte sedimentation rate may be elevated in active tuberculosis, but 
a normal sedimentation rate is not necessarily excluding the disease. Anaemia is the 
commonest haematological abnormality being more evident in the disseminated 
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forms of TB. The use of genetic-based tests may be helpful for further classification 
of patients with AFB smear positive disease. However, it is not practical for routine 
screening (Sepkowitz, 2001). Nucleic acid amplification technique and cultivation of 
Mycobacterium are helpful. Polymerase chain reaction and serologic tests are 
expensive with low-proven values especially for poor countries (Gandy & Zumla, 
2002). 
 
2.1.2(c) Radiology investigation     
 Chest X-ray findings are helpful although it is non-specific; because as per 
FitzGerald et al. (1991) report, 10% of pulmonary TB patients have normal chest X-
rays (Sepkowitz, 2001). Changes in the roentgenogram may precede symptoms. 
Serial films are always more helpful than single radiology report.  X-ray findings 
should be compared and interpreted with physical signs. The absence of abnormal 
findings cannot rule out tuberculosis. The presence of abnormal signs may not also 
necessarily mean tuberculosis. Cavitations, formation of scar with loss lung 
parenchyma volume and calcifications may be considered as indications of 
tuberculosis (China TB Control Collaboration, 2004). The extent of disease on X-ray 
was graded into 4 categories: normal, minimal, moderately advanced, and far 
advanced (Guwatudde, 2003).  
 
2.1.2(d) Tuberculin Skin Test     
 Mantoux test is to diagnose TB infection for subjects who are at risk of TB 
infection. In the past, tuberculin test was of special importance for all practical 
purposes of TB diagnosis, except for the first three to seven weeks after infection. 
Failure to react to intracutaneous tuberculin was used to rule out active tuberculosis. 
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Recent tuberculin positive conversion after serial tests with negative results is of 
great value.  If illness or X-ray changes occur, converters may be treated as 
tuberculous with confidence. Currently tuberculosis skin test using purified protein 
derivative (PPD) is used for the identification of latent TB infection. However, there 
is no reliable method of distinguishing tuberculin reactions caused by vaccination 
with BCG from those caused by natural Mycobacterium infection. PPD is not 
routinely applicable for poor countries (Gandy & Zumla, 2002). Low sensitivity in 
immune-compromised patient, cross reactivity with BCG vaccine and environmental 
Mycobacterium, the longer time required for the result of the test (48-72 hours), and 
the interpretation of the result are limitations of tuberculin skin test according to 
Huebner et al., 1993 (Thomas et al., 2003). Interpretation of tuberculin skin test 
depends on the prevalence of TB in specific geographical areas, the likelihood of TB 
infection, and comorbidity with other diseases.  
 
In certain countries, especially those with low rate of TB, any test above 5- 
mm is considered as infection. In countries like China, the test is considered positive 
if, induration of 10 mm or higher was noted during 72 hours (Tuberculosis Control, 
China, 2004). However, in other countries with high TB burden and where a large 
proportion of adults and children have been immunized, the definition of positive 
skin test may be different. In subjects with BCG scar, it is impossible to distinguish 
between infection and immunization (Zangger et al., 2001). An increase in size by 5 
mm between first and second test is considered to be suggestive of primary infection.  
In certain cases, like HIV patients, subjects with close contacts of infectious cases, 
and cases with fibrotic lesions on chest radiography, a reaction of 5 mm and upward 
is considered as positive. For subjects who are at risk, 10 mm and higher tuberculin 
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reaction is considered positive.  By any means, reaction of 15 mm and above, the test 
is considered as a positive. 
 
2.1.2(e) Biopsy 
Fine needle aspiration cytology and other operations are used for suspected 
TB cases when other investigations could not finalize the diagnosis. Lymph node 
biopsy is an example of these procedures. 
 
2.1.2(f) Other Diagnostic Measures 
Patients with abnormal X-ray are treated with antibiotics as a diagnostic tool 
to differentiate tuberculosis from chest infection due to other bacterial species. Those 
not improved with antibiotics indicate more intense suspicion of TB infection.  
  
2.1.3 TB Diagnoses and Resources 
In general, diagnosis of TB is economic resources dependent. In countries 
with high prevalence of tuberculosis, possibility that direct smear positivity is due to 
Mycobacterium TB is more than 95%. Sputum cultures and individual drug 
susceptibility testing are expensive for poor countries and not necessary. For low 
resource countries, WHO recommends sputum microscopy and staining for acid fast 
bacilli. Higher resource countries, chest x-ray, sputum culture and susceptibility 
testing are used.  
 
2.1.4 Classification of TB Diagnoses      
TB cases are classified (according to the final labelling) into definite TB 
infection if culture results confirm TB; probable TB, when smear is positive, and 
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clinical presentation consistent with TB or moderate chest X-ray abnormality and 
response to anti-TB regimen. The possible TB is diagnosed if clinical presentation is 
consistent with TB; otherwise it is unlikely tuberculosis. 
 
2.1.5 Non Tuberculous Mycobacterium      
Differentiation of TB from other nontuberculous Mycobacterium is important 
for the final diagnosis of TB. Introduction of new technology in laboratory that can 
easily recognize nontuberculous Mycobacterium (NTM) and improvement in health 
services in many countries helped the isolation of NTM (Martin-Casabona, 2004).  
 
2.1.6 Pathogenesis of Tuberculosis 
TB is a member of bacterial groups known as Mycobacterium which contain 
M. tuberculosis, M. bovis, M. africanum, M. microti, and M. canetti. M. tuberculosis 
is transmitted via airborne from human to human, and there no known animal 
reservoir. The disease is transmitted from one person to another through the air. Air 
droplet nuclei are produced when the person with TB infection is singing, laughing, 
or talking. The droplets that contain germs of bacteria are suspended in the air; when 
someone breathes in the droplets of air containing TB germs, he becomes infected 
with TB. The size of the particles generated is important. Air droplets with particle 
size 1-5 microns in diameter are capable of inducing infection, because such particles 
are small and they penetrate the alveoli of the lungs. Also, these small air droplets 
can spread in the air easily and can be kept airborne for long time. Larger particles 
that are produced by TB patients, although they contain numerous bacilli, do not 
serve as effective media for disease transmission. These particles do not remain 
airborne, and if inhaled, do not reach alveoli. The airborne droplet containing M. 
tuberculosis remains the source of infection for minutes to hours after expectoration. 
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Once inhaled, the air droplet nucleus containing M. tuberculosis is transported 
through bronchial tree and deposited on a respiratory bronchiole or alveolus. The 
bacterium is then taken up by alveolar macrophages which is the starting point of 
struggle between exposed person immune system and the infection with the resultant 
of either successful containment of the bacteria or progression to active TB.  
 
The risk of the TB infection is dependent on the duration of contact, and the 
extent of exposure. Infection with TB usually requires repeated, close, and long time 
contact. Transmission of M. tuberculosis is governed by the number and 
concentration of organisms expelled into the air, and the virulence of the organism. 
In the terms of proximity, TB cases among family members and close friends are 
considered first contact group, while classmate and teachers are classified as second 
contact group.  M. tuberculosis grows shortly over 2-12 weeks until they reach 1000-
10000 in number which is sufficient to provoke cellular immune interaction with 
tuberculin skin test. At this stage there is no sign of TB infection and a positive 
tuberculin skin test is the only indication for the presence of M. tuberculosis. 
Tubercle bacilli first spread through lymphatics to the hilar lymph nodes and then 
through blood stream to more distant sites. The host immune system like activated T 
cells and macrophages from granulomas limit the growth and the spread of 
tuberculosis. However, granulomas may contain only a few viable bacilli. The risk of 
developing TB is greatest during the first two years. Even if someone becomes 
infected with TB, the body defence mechanisms contain the infection and the person 
does not become sick easily. About 10% of infected persons with TB may develop 
tuberculosis in their life time. The remaining 90% will never get sick from TB 
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infection. Infection with TB is different from becoming sick with TB infection. The 
former is known as latent infection, while the latter is known as tuberculosis.  
 
Tuberculosis may result from latent infection or from direct contact of active 
tuberculous patient. Someone who has been infected with TB for years gets change 
in health condition, body defence becomes weak, and the hidden latent infection 
becomes overt. In other ways, someone may first get tuberculosis by breathing in the 
TB germs directly from a sick patient, and the body is unable to protect itself against 
the disease. Adult patients with pulmonary TB may infect people in their 
environment because of their ability to produce sputum and transmit the germs than 
children do. Although transmission is possible, children and adolescents are rarely 
contagious (Zangger et al., 2001). Patients with acid fast bacilli (AFB) smear 
positive are more infectious, and each of these patients may go on to infect 10-15 
persons per year if they are not treated. Sputum-smear positive cases are not only 
more infectious than smear negative case, but have higher fatality cases. Coexisting 
diseases such as HIV, diabetes, silicosis, treatment with steroids increase the chance 
of tuberculosis disease.  
 
2.1.7 Tuberculous Related Complications  
  Tuberculosis related complications are documented for both pulmonary and 
extra-pulmonary TB. Tuberculosis is a bacterial infectious disease that usually 
attacks the lung, but it can affect any other parts of the body too. Anatomically, 
tuberculosis infection is divided into pulmonary and extra-pulmonary. The ratio of 
pulmonary to nonpulmonary depends on numerous factors such as geographical, and 
other coexisting diseases such as HIV and diabetes mellitus (American Thoracic 
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Association, 2000). The main site of the clinical manifestation is the lung. The lymph 
mode is the anatomical site that is affected mainly by extra-pulmonary TB. 
Tuberculosis lymphadenitis can be primary or postprimary.  
 
Primary tuberculosis lymphadenitis that occurred as a complication after 
vaccination with BCG vaccine has been reported (Jakubikovả et al., 1996). 
Haematological complications were noted by numerous workers in pulmonary, 
disseminated, and pleural TB cases. In a Malaysian study, thrombocytosis and 
lymphocytopenia in TB patients were reported (Aweis et al., 2010). Lymphocytosis 
was observed in 69% of paediatric patients with abdominal TB (Veeragandham, 
1996). Increased erythro-sedimentation rate, anaemia, leukocytosis, neutrophilia, 
severe lymphocytopenia, leucopenia, monocytosis, thrombocytosis, 
thrombocytopenia, and lymphocytosis were reported (Kony et al., 2000; Onarati, 
2001; Singh, 2001). In addition to anaemia, thrombocytosis and hypercoagulable 
states that disappear 30 days after anti TB drugs initiation have been reported. This 
hyper-coagulable state may affect negatively patients with deep venous thrombosis 
(Turken et al., 2002).    
 
Acute respiratory distress due to airway narrowing caused by enlarged 
tuberculous mediastinal lymph nodes was reported by Worthington et al. (1993). 
These respiratory complications developed or progressed soon after the initiation of 
anti-TB drugs. New or worsening of lymphadenopathy, fever, cerebral tuberculosis, 
and pleural effusion have also been noted. As suggested by Fisman et al. (2000), 
these reactions were linked to possible improved cell mediated immune function that 
might be secondary to damage of alveolar capillary membranes (Akira, 2001). Acute 
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respiratory distress resulting from mediastinal lymph node enlargement with critical 
compression of major airways requiring thoracic surgery in paediatric subjects with 
pulmonary TB was reported (Awad, 2002). 
 
Respiratory failure is one of the complications of extra pulmonary TB. 
Respiratory failure secondary to extrinsic compression on the airways by enlarged 
lymph nodes is managed by decompressing the lymph by incision and not by 
excision. All these procedures require early intervention by multidisciplinary 
involvement and careful joint management (Awad, 2002).  
 
Complication of TB can affect any part of gastrointestinal tract (GIT), from 
the oesophagus to the anal canal. Tuberculosis of GIT can be secondary to a primary 
focus in any part of the body or can develop primarily within intestinal tract. It is 
difficult to distinguish it from malignancy, Crohn's disease, appendicitis, and 
ulcerative colitis. Even in endemic areas the accuracy of clinical diagnosis is poor. 
Rectal tuberculosis is rare and accounts for 4.5% of the GIT tuberculosis. Because of 
its similarity to carcinoma its diagnosis is difficult. Diagnosis of oesophageal 
tuberculosis is difficult and requires a combination of different diagnostic methods. 
Dysphagia, cough related to the meals and chest pain as a result of esophageal 
fistulas were reported by Rämö et al. (1996).  
 
Multiple drug resistant (MDRTB) is one component of TB complications. 
Although chemotherapy is the mainstay of all TB cases, surgery is reserved for the 
diagnosis or for the management of certain complicated cases like MDRTB. The 
rationale for considering operation is to excise specific areas where the TB bacilli 
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can hide itself from the effects of host defence mechanism and anti-TB drug therapy. 
Usually these areas are the gross cavitations where the nature of these areas can 
provide protection for the TB organisms. By ablation of cavitations, there is a 
possibility that the protective nature of cavitations is reduced and the organisms 
come in direct contact with the host defence system and chemotherapy.  
 
Patients who remain smear/culture positive, despite adequate drug therapy 
containing appropriate drugs to which the resistant Mycobacterium TB strains are 
sensitive, are considered as candidates for the operation. It is not easy to specifically 
diagnose the area (reservoir) of resistant bacilli. A higher percentage of 
nonconversion rates among lobectomies (partial resection) compared to 
pneumnectomies was reported (Leuven et al., 1997).  
 
Pneumothorax as a complication of TB has been reported and about 58.3% of 
pneumothorax cases were correlated with tuberculosis. Combined pneumothorax and 
active TB showed severe clinical conditions, demanding for more operative 
procedures like thoractomy, longer catheter aspirations and hospital stay (Blanco-
Perez et al., 1993). Surgical operation is necessary for tuberculosis fistulas of the 
oesophagus for safety and more rapid recovery than by medical management alone 
and for diagnostic reason. Rectal TB responds very well with drug treatment. 
However, if the stenosis (stricture) persists for 3-6 months post chemotherapy, 
surgery is recommended for both treatment and diagnosis of possible coexisting 
malignancy (Das, 1996).  
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2.1.8 Treatment of TB 
The hope to overcome TB disease is dependent on socio-political 
commitment that includes appropriate fund allocation with especial emphasis on 
society and health professional education, case detection and proper diagnosis, 
treatment with appropriate drugs, good supervision, and reduction of the patient's 
sufferance and financial load. Many patients have no realistic access to health 
facilities. The coexistence of HIV and TB is a complex matter that makes treatment 
difficult. The injectable drug, streptomycin, can become a source of HIV 
transmission if multiple uses of syringes applied. Stigmas that result from HIV and 
TB, is one of the obstacles for the eradication of TB (Saunderson, 1995).  
 
Ensuring the completion of treatment for patients with TB is the most 
important issue of TB control. The ultimate elimination of tuberculosis requires an 
organized and smoothly functioning network of primary referral services based on 
cooperation between clinicians and public health programs. To ensure that the 
disease is treated appropriately, understanding the patients' perspective is important 
(Needham et al., 2003). TB treatment outcome is dependent on the structure and the 
managing team (Lin et al., 2006). In Taiwan, improved compliance with the 
treatment as a result of incentives paid to the patients was reported (Tsai et al., 
2010). The newer short-course regimen is very cost effective. Cure rate of up to 86% 
was documented in Tanzania, the first country that implemented short-course 
chemotherapy regimen (Wyss et al., 2001).  
 
 
 
